| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |